Millennium Management’s MacroGenics MGNX Stock Holding History

Millennium Management’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-35,500	Closed	-$313K	–	7280
2022 Q1	$313K	Buy	+35,500	New	+$392K	﹤0.01%	5495
2020 Q3	–	Sell	-27,500	Closed	-$768K	–	4678
2020 Q2	$768K	Hold	27,500	–	–	﹤0.01%	3148
2020 Q1	$160K	Sell	27,500 -272,500	-91%	-$2.47M	﹤0.01%	3462
2019 Q4	$3.26M	Hold	300,000	–	–	﹤0.01%	2257
2019 Q3	$3.83M	Buy	+300,000	New	+$4.32M	0.01%	2009

Other funds holding MGNX

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Millennium Management's MGNX Position: Q1 2026 in Review

Millennium Management increased its MacroGenics (MGNX) stake by 42% in Q1 2026, buying an estimated $1.75M and bringing the position to 2,794,357 shares worth $8.08M. The position accounts for ﹤0.01% of the portfolio, ranked #2390.

Millennium Management first reported a position in MGNX in Q1 2014 and has held it in 49 quarters since. The position peaked at $50M in Q2 2019. 109 funds tracked by Wall St. Rank hold MGNX as of Q1 2026.

Millennium Management held 2,794,357 shares of MacroGenics worth $8.08M as of Q1 2026.
Millennium Management bought 819,877 MacroGenics shares in Q1 2026, an estimated $1.75M.
MacroGenics made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #2390 holding.
Millennium Management first reported a position in MacroGenics in Q1 2014 and has held it in 49 quarters since.
Millennium Management's MacroGenics position peaked at $50M in Q2 2019.
109 funds tracked by Wall St. Rank held MacroGenics as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.